AI-driven drug discovery startup targets rare disease therapeutics

An entrepreneur and a physician have partnered to utilize artificial intelligence for accelerating the development of treatments for rare diseases. The initiative aims to transition from academic research to a commercially viable business model, emphasizing the necessity of profitability over philanthropic-only approaches.